The present invention is concerned with 2-aminoquinoline derivatives of formula I
where R1, R2, R3, R4, R5, R6, A, and n are as defined in the specification and claims, their use 5-HT5A receptor antagonists, their manufacture, and pharmaceutical compositions containing them.
The present invention is concerned with 2-aminoquinoline derivatives of formula I
where R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A, and n are as defined in the specification and claims, their use 5-HT
5A
receptor antagonists, their manufacture, and pharmaceutical compositions containing them.